SGLT2i pharmacological treatment in type 2 diabetes mellitus control and its underlying obesity. Rev Port Med Geral Fam [Internet]. 30 de abril de 2024 [citado 17 de abril de 2026];40(2):148-56. Disponível em: https://rpmgf.pt/ojs/index.php/rpmgf/article/view/13647